LAUSANNE, Switzerland, Dec. 2, 2024 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that ...

Spyre Therapeutics, Inc. (NASDAQ: SYRE ) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and ...

SoundHound AI, Inc. , a global leader in voice artificial intelligence, today announced that it will participate in the following investor conferences in December: Nitesh Sharan, SoundHound CFO, will ...

Natural Grocers®, America's Nutrition Education ExpertsSM and the nation's largest family-operated organic and natural grocery retailer, has unveiled its highly anticipated Top Trends for 2025. Now in ...

The U.S. Food and Drug Administration gave SC291, a CD19-directed allogeneic CAR T cell therapy developed using Sana's hypoimmune platform, fast track designation, a process designed to facilitate the ...